Metronomic cyclophosphamide and capecitabine combined with lapatinib in heavily pretreated metastatic breast cancer (MBC) HER2-positive patients. This is an ASCO Meeting Abstract from the 2012 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results